Regulated Information
Availability of the 2023 Universal Registration Document
Press releases95.34 KB • March, 28th 2024
Disclosure of the number of shares forming the capital and of the number of voting rights as of 29 02 2024
Voting rights75.48 KB • March, 18th 2024
Elis successfully priced a €400 million note issuance under its EMTN Programme
Press releases61.93 KB • March, 14th 2024
EMTN - First Supplement to the Base Prospectus 2023
Prospectus832.02 KB • March, 12th 2024
Full-year 2023 results - Presentation
Financial presentations3.06 MB • March, 7th 2024
2023 financial statements
Annual financial reports3.23 MB • March, 7th 2024
Full-year 2023 results - Press release
Financial releases337.45 KB • March, 7th 2024
Elis closes the acquisition of Moderna Holding BV in the Netherlands
Press releases50.31 KB • February, 26th 2024
Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 01 2024
Voting rights75.69 KB • February, 22nd 2024
Full-year 2023 revenue (presentation)
Financial presentations2.67 MB • January, 30th 2024